In the Media
Are you looking for the latest media coverage of the BioMed X Institute, its research projects and people behind the innovation model? Here you will find the latest clippings – hot off the press!
Visit: BioMed X and Boehringer Ingelheim are expanding their joint XSeed Labs incubator in Ridgefield, Connecticut, with the launch of a second research group focused on next-generation intraocular biologics
BioMed X and Boehringer Ingelheim are expanding their joint XSeed Labs incubator in Ridgefield, Connecticut, with the launch of a second research group focused on next-generation intraocular biologics
Labmate Online
Visit: BioMed X and Boehringer Ingelheim expand joint XSeed labs incubator in the US
BioMed X and Boehringer Ingelheim expand joint XSeed labs incubator in the US
BioSpectrum Asia
Visit: Exploring Collaboration Opportunities: Five German Medical Innovation Companies Visit Taiwan
Exploring Collaboration Opportunities: Five German Medical Innovation Companies Visit Taiwan
工商時報
Visit: Taiwan-Germany Biotech Alliance: German Companies Seek Business Opportunities in Taiwan
Taiwan-Germany Biotech Alliance: German Companies Seek Business Opportunities in Taiwan
GeneOnline
Visit: Five German medical innovation companies visited Taiwan
Five German medical innovation companies visited Taiwan
Yahoo Taiwan Finance
Visit: German Business Office Taipei organizes Taiwan-Germany Conference on Healthcare Applications
German Business Office Taipei organizes Taiwan-Germany Conference on Healthcare Applications
Radio Taiwan International
Visit: Five major German medical innovation companies visited Taiwan to expand cooperation opportunities in elderly and cancer medicine
Five major German medical innovation companies visited Taiwan to expand cooperation opportunities in elderly and cancer medicine
grinews
Visit: Germany strengthens healthcare ties with Taiwan, spotlighting precision medicine and biotech innovations
Germany strengthens healthcare ties with Taiwan, spotlighting precision medicine and biotech innovations
DIGITIMES
Visit: The BioMed X Institute, Boehringer Ingelheim Launch Call for Research Proposals
The BioMed X Institute, Boehringer Ingelheim Launch Call for Research Proposals
Contract Pharma
Visit: BioMed X and Boehringer Ingelheim Expand Joint XSeed Labs Incubator in the U.S.
BioMed X and Boehringer Ingelheim Expand Joint XSeed Labs Incubator in the U.S.
FirstWord PHARMA
Visit: The German medical innovation group visited Taiwan to seek cooperation
The German medical innovation group visited Taiwan to seek cooperation
DIGITIMES
Visit: BioMed X expands with Boehringer Ingelheim to join the combined XSeed Labs incubator in the United States
BioMed X expands with Boehringer Ingelheim to join the combined XSeed Labs incubator in the United States
等信源发布
Visit: The goal of our new XBridge program is to open a new door for researchers facing the sudden loss of support.
The goal of our new XBridge program is to open a new door for researchers facing the sudden loss of support.
Manager.bg
Visit: BioMed X has started a program to match researchers who have previously received funding from the U.S. National Institutes of Health (NIH) who have lost funding with supporters from the pharmaceutical industry.
BioMed X has started a program to match researchers who have previously received funding from the U.S. National Institutes of Health (NIH) who have lost funding with supporters from the pharmaceutical industry.
Thansettakij
Visit: BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
Sina Finance
Visit: BioMed X has launched a program to match U.S. National Institutes of Health fellows who have lost funding sponsors from the pharmaeceutical industry.
BioMed X has launched a program to match U.S. National Institutes of Health fellows who have lost funding sponsors from the pharmaeceutical industry.
Bloomberg Línea
Visit: BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
HKEJ
Visit: BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
CNYES
Visit: BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
Lianhe Zaobao
Visit: BioMed X partners with the Barbadian Government to optimise cardiometabolic treatment options
BioMed X partners with the Barbadian Government to optimise cardiometabolic treatment options
Manufacturing Chemist
Visit: Promotion of local pharmaceutical production
Promotion of local pharmaceutical production
Kurzy